Intervention: Monoclonal antibodies

SOLIDARITY Finland Plus Long-COVID

Finland
|
2022-2025
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Immnunomodulator
  • Antineoplastic agent
  • Imatinib
  • Infliximab
  • Monoclonal antibodies

NOVELLA

Russian Federation
|
2023-2024
  • Adults
  • Elderly
  • Immunocompromised host
  • Fragile population
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • AZD3152
  • Monoclonal antibodies

Leppert

Italy Spain Switzerland
|
2022-2024
  • Adults
  • Elderly
  • General population
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Temelimab
  • Monoclonal antibodies

Evans

United Kingdom
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Outpatient clinic
  • Non-hospital health centre
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Molnupiravir

Drysdale

United Kingdom
|
2021-2022
  • Adults
  • Paediatric
  • Elderly
  • Immunocompromised host
  • Fragile population
  • Outpatient clinic
  • Non-hospital health centre
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab